Literature DB >> 9180907

Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.

G Perilongo1, M Massimino, G Sotti, T Belfontali, L Masiero, L Rigobello, L Garrè, M Carli, F Lombardi, C Solero, L Sainati, V Canale, A B del Prever, F Giangaspero, L Andreussi, C Mazza, E Madon.   

Abstract

The principal aim of this report is to present the results of multivariate analyses conducted to identify clinical prognostic factors in 92 children aged < 16 years with ependymoma (EPD) retrospectively collected in seven Italian centres. They were treated over a 16-year period (1977-1993). Treatment modalities varied. Surgery and radiotherapy (RT) was the "gold standard" management method for the majority of these children. Only in the late 1980s did some of them receive chemotherapy (CT), mainly with vincristine, lomustine (CCNU) and prednisone. The median follow-up of the entire study population is 36 months (average 43 months; range 12 to 214 months). The 10-year overall (OS) and the progression-free survival (PFS) of the study population were 55.5% (CI 41.4-69.4%) and 34.7% (CI 21.4-47.8%), respectively. Age (< 5 years; > 5 years), sex, site (infratentorial vs. supratentorial), histology (anaplastic/malignant vs. non-anaplastic/non-malignant), type of resection (complete vs. incomplete); use and fields of RT, and of CT employed were entered in a multivariate regression model to test their impact on OS and PFS. On univariate analysis, radical surgery, the use of RT and age more than 5 years at the time of diagnosis achieved statistically significant values for predicting long-term OS and PFS. Histology reached marginal statistical significance but only for PFS. When those variables were entered in a multivariate analysis only radical resection (P = 0.00142 and 0.0001) resulted a significant factor for predicting long-term OS and PFS, while the use of RT reached a marginal statistical significance, but only for PFS (P = 0.05). Children who had the tumour completely resected did significantly better than all the others who had less than a complete resection, with a 10-year OS and PFS for the two groups of patients of 69.8% (CI 53-86.5%) and 57.2% (CI 40.3-75%) and of 32.5% (CI 8.5-57.6%) and 11.1% (0-24.4%), respectively. These findings suggest that, for childhood EPD, radical resection should be pursued as much as reasonably possible. Thus, it seems justified proposing for future trials, patient stratification by entity of surgical resection.

Entities:  

Mesh:

Year:  1997        PMID: 9180907     DOI: 10.1002/(sici)1096-911x(199708)29:2<79::aid-mpo3>3.0.co;2-o

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  57 in total

1.  The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience.

Authors:  Tamir Ailon; Christopher Dunham; Anne-Sophie Carret; Uri Tabori; P Daniel Mcneely; Shayna Zelcer; Beverley Wilson; Lucie Lafay-Cousin; Donna Johnston; David D Eisenstat; Marianna Silva; Nada Jabado; Karen Jane Goddard; Chris Fryer; Glenda Hendson; Cynthia Hawkins; Sandra Dunn; Stephen Yip; Ashutosh Singhal; Juliette Hukin
Journal:  Childs Nerv Syst       Date:  2014-11-13       Impact factor: 1.475

2.  Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma.

Authors:  Matthew Koshy; Shayna Rich; Thomas E Merchant; Usama Mahmood; William F Regine; Young Kwok
Journal:  J Neurooncol       Date:  2011-06-03       Impact factor: 4.130

3.  Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.

Authors:  Sara Dyer; Emma Prebble; Val Davison; Paul Davies; Pramila Ramani; David Ellison; Richard Grundy
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  Pediatric anaplastic parenchymal ependymoma: case report.

Authors:  Murat Kutlay; Ahmet Cetinkal; Serdar Kaya; Mehmet N Demircan; Murat Velioglu; Ufuk Berber
Journal:  Childs Nerv Syst       Date:  2010-11-26       Impact factor: 1.475

5.  Intensity modulated radiation therapy or stereotactic fractionated radiotherapy for infratentorial ependymoma in children: a multicentric study.

Authors:  Damien C Weber; Thomas Zilli; Hans Peter Do; Philippe Nouet; Fabienne Gumy Pause; Fabienne Gumy Pause; Alessia Pica
Journal:  J Neurooncol       Date:  2010-08-20       Impact factor: 4.130

6.  New chemotherapy strategies and biological agents in the treatment of childhood ependymoma.

Authors:  Karen D Wright; Amar Gajjar
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

Review 7.  The role of stereotactic radiotherapy in the management of ependymomas.

Authors:  Mark D Krieger; J Gordon McComb
Journal:  Childs Nerv Syst       Date:  2009-04-09       Impact factor: 1.475

Review 8.  Supratentorial pediatric cortical ependymomas: a comprehensive retrospective study.

Authors:  Qiguang Wang; Jian Cheng; Si Zhang; Qiang Li; Xuhui Hui; Yan Ju
Journal:  Neurosurg Rev       Date:  2020-06-30       Impact factor: 3.042

9.  The use of neoadjuvant chemotherapy to achieve complete surgical resection in recurring supratentorial anaplastic ependymoma.

Authors:  Elvis Terci Valera; Helio Rubens Machado; Antonio Carlos Santos; Ricardo Santos de Oliveira; David Araújo; Luciano Neder; Luiz Gonzaga Tone
Journal:  Childs Nerv Syst       Date:  2004-08-27       Impact factor: 1.475

Review 10.  Classification and controversies in pathology of ependymomas.

Authors:  Catherine Godfraind
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.